Kushal Chhabra, MD
Internal Medicine · San Ramon
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
- Since medical school
- 31 years
- Graduated 1995
Offices
3 locations · John Muir Physician Network · Sutter Bay Medical Foundation
Looking this up.
Hospitals listed: John Muir Medical Center - Concord Campus · John Muir Medical Center - Walnut Creek Campus · San Ramon Regional Medical Center · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Chhabra’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A90362 · Current
Licensed to practise in California · since 2005 · expires 2027-03-31 · University of Health Sciences Vijayawada, Osmania Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
Hospitals they work in
4 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- John Muir Medical Center - Concord CampusConcord, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of John Muir Health, which runs 3 hospitalsPatients rate it 3 of 5 · 77% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.235, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.675, Oct 2024 – Sep 2025
- John Muir Medical Center - Walnut Creek CampusWalnut Creek, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of John Muir Health, which runs 3 hospitalsPatients rate it 3 of 5 · 77% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — Abdominopelvic accidental puncture or laceration rate: 2.01 (1.17 to 2.85) · 2,206 cases, Jul 2022 – Jun 2024Worse than the national rate — Death rate among surgical inpatients with serious treatable complications: 222.42 (177.82 to 267.02) · 120 cases, Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 1.4 (0.91 to 1.9) · 9,764 cases, Jul 2022 – Jun 2024Worse than the national rate — SSI - Colon Surgery: 2.734, Oct 2024 – Sep 2025Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.536, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.341, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.455, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.245, Oct 2024 – Sep 2025
- San Ramon Regional Medical CenterSan Ramon, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of Tenet Healthcare, which runs 77 hospitals in 12 statesPatients rate it 3 of 5 · 65% would definitely recommend itOverall rating: 4 of 5 starsNo measure marked better or worse than the national rate
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for John Muir Medical Center - Concord Campus
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 0 better, 7 the same, 0 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.235 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.675 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.11 (0.21 to 2) · 1,612 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.77 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 184.13 (136.65 to 231.6) · 86 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.2 · 175 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.6 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.4 · 172 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8 · 537 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.5 · 434 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 13 · 215 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 3,208 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.32 (0.13 to 0.51) · 7,626 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.04 to 0.41) · 8,660 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.1 (1.29 to 4.91) · 2,723 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.21 (0 to 2.51) · 1,208 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3 (1.7 to 4.3) · 2,355 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.77 (3.24 to 12.3) · 1,216 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.43 (0.43 to 6.43) · 1,253 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.93 (0.47 to 3.4) · 388 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.14 (0.58 to 1.69) · 6,288 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.1 · 263 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.636 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.254 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.904 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.5 · 312 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.1 · 768 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -6.8 · 295 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.1 · 648 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 31.1 · 433 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 504 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.7 (5.1 to 8.8) · 476 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.9 (10.5 to 15.7) · 476 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 250 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 8.8 · 154 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.7 · 186 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (9.9 to 17.9) · 192 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.2) · 546 cases | No different | Jan 2024 – Dec 2024 |
What patients said (521 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 77% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
See every measure and the patient survey for John Muir Medical Center - Walnut Creek Campus
Behind the star rating — Deaths: 3 better, 2 the same, 2 worse of 7 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 3 better, 5 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 2.01 (1.17 to 2.85) · 2,206 cases | Worse | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 222.42 (177.82 to 267.02) · 120 cases | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.4 (0.91 to 1.9) · 9,764 cases | Worse | Jul 2022 – Jun 2024 |
| SSI - Colon SurgeryInfections | 2.734 | Worse | Oct 2024 – Sep 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.536 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.341 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.455 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.245 | Better | Oct 2024 – Sep 2025 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.14 (0.87 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 131 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 148 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 695 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.5 · 827 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 14.1 · 509 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 4,483 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.35 (0.18 to 0.53) · 11,630 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.05 to 0.39) · 11,793 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.33 (1.69 to 4.96) · 3,268 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.37 (0 to 2.94) · 1,631 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.76 (1.43 to 4.09) · 3,066 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.12 (0.22 to 12.02) · 1,580 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.43 (1.21 to 7.64) · 1,594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.82 (0.4 to 3.24) · 685 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 615 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 1.88 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.7 · 93 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 729 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -30.1 · 91 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13 · 736 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 34.8 · 842 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.7 · 818 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.3 (3.3 to 8.4) · 28 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (7.2 to 15.5) · 28 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 584 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.4 · 139 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.9) · 222 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 321 cases | No different | Jan 2024 – Dec 2024 |
What patients said (758 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 69% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 77% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for San Ramon Regional Medical Center
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 0 better, 4 the same, 0 worse of 4 measures. Readmissions: 0 better, 7 the same, 1 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.94 (0 to 1.97) · 507 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.83 (0.44 to 1.22) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.1 · 36 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.8 · 87 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.2 · 195 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.7 · 284 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 63 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,118 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 2,515 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.08 to 0.49) · 2,618 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.62 (1.26 to 5.98) · 588 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0 to 3.14) · 282 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.34 (0.72 to 3.97) · 598 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.12 (0.84 to 15.4) · 258 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.08 (0.25 to 7.91) · 225 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.02 (0.52 to 3.52) · 241 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.32 (0 to 1.29) · 2,110 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 73 cases | None | Apr 2023 – Mar 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.553 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.104 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 84 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.2 · 186 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 39.6 · 79 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -10.3 · 227 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -5.2 · 305 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 314 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.9 · 84 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 37 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (9.4 to 17.3) · 86 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 256 cases | No different | Jan 2024 – Dec 2024 |
What patients said (642 patients answered, 25% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 65% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 65% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$56,500
Medicare paid this office $56,500 for 276 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 118 | $13,285 | $66 |
| Short return visit (20+ min) | 170 | $13,264 | $56 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 107 | $5,643 | $53 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 18 | $5,193 | $289 |
| Influenza vaccine split virus, preservative free | 36 | $2,946 | $82 |
See all 17 services
| Return visit (30+ min) | 118 | $13,285 | $66 |
| Short return visit (20+ min) | 170 | $13,264 | $56 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 107 | $5,643 | $53 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 18 | $5,193 | $289 |
| Influenza vaccine split virus, preservative free | 36 | $2,946 | $82 |
| New patient visit (45+ min) | 23 | $2,919 | $127 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 14 | $2,764 | $197 |
| Sarscov2 vac 50 mcg/0.5ml im | 11 | $1,743 | $158 |
| Administration of influenza virus vaccine | 38 | $1,470 | $39 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 77 | $1,279 | $15 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | 16 | $1,102 | $69 |
| Long return visit (40+ min) | 12 | $1,077 | $90 |
| Administration of pneumococcal vaccine | 17 | $658 | $39 |
| Admn sarscov2 vacc 1 dose | 11 | $567 | $52 |
| Short return visit | 11 | $548 | $50 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 24 | $321 | $13 |
| Urinalysis, manual test | 22 | $102 | $3 |
Who their Medicare patients are
276 Original Medicare patients in 2024. Average age 74 · Women 69% · Also on Medicaid 11% · Health risk score 0.90. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 59% · Diabetes 20% · Chronic kidney disease 17% · Atrial fibrillation 15% · Coronary heart disease 14% · Cancer 13% · Depression 13% · Heart failure 9% · COPD 8% · Stroke 5% · Dementia 4%.
The office billed $210,211, Medicare allowed $78,060 and paid $56,500; for 955 services of 30 kinds; $10,145 of it was for drugs given in the office and $46,355 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 276 | 955 | 74 | 0.90 | $210,211 | $56,500 |
| 2023 | 256 | 832 | 74 | 1.01 | $181,569 | $49,658 |
| 2022 | 233 | 750 | 74 | 1.02 | $153,852 | $38,996 |
| 2021 | 202 | 712 | 73 | 0.84 | $143,653 | $38,412 |
| 2020 | 198 | 570 | 74 | 1.02 | $98,296 | $35,753 |
| 2019 | 280 | 756 | 74 | 1.03 | $130,351 | $47,767 |
| 2018 | 275 | 682 | 73 | 1.22 | $135,174 | $44,920 |
| 2017 | 215 | 657 | 74 | 1.07 | $111,931 | $42,166 |
| 2016 | 184 | 536 | 73 | 0.90 | $62,442 | $39,519 |
| 2015 | 184 | 497 | 73 | 0.83 | $52,329 | $36,282 |
| 2014 | 150 | 332 | 74 | 0.90 | $36,200 | $23,080 |
| 2013 | 127 | 286 | 74 | 0.84 | $29,679 | $19,363 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Short return visit (20+ min) | 155 | $12,656 | $53 |
| Return visit (30+ min) | 102 | $8,833 | $63 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 25 | $7,063 | $283 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 111 | $6,588 | $59 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 34 | $2,578 | $76 |
| New patient visit (45+ min) | 15 | $1,773 | $118 |
| Administration of influenza virus vaccine | 33 | $1,198 | $36 |
| Short return visit | 23 | $1,033 | $45 |
| Administration of pneumococcal vaccine | 26 | $944 | $36 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 22 | $292 | $13 |
| Urinalysis, manual test | 29 | $113 | $3 |
2022: 11 services
| Short return visit (20+ min) | 132 | $11,299 | $51 |
| Return visit (30+ min) | 88 | $8,046 | $60 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 94 | $4,938 | $53 |
| Telephone medical discussion with physician, 21-30 minutes | 15 | $2,633 | $101 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 29 | $2,026 | $70 |
| Pneumococcal vaccine, 23-valent | 11 | $1,458 | $133 |
| Administration of influenza virus vaccine | 32 | $1,178 | $37 |
| Telephone medical discussion with physician, 11-20 minutes | 13 | $912 | $65 |
| Administration of pneumococcal vaccine | 15 | $556 | $37 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 21 | $291 | $14 |
| Urinalysis, manual test | 17 | $79 | $3 |
2021: 11 services
| Short return visit (20+ min) | 113 | $9,527 | $51 |
| Return visit (30+ min) | 91 | $7,531 | $59 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 100 | $5,946 | $59 |
| Pneumococcal vaccine, 23-valent | 20 | $2,494 | $125 |
| Telephone medical discussion with physician, 11-20 minutes | 22 | $1,993 | $74 |
| Telephone medical discussion with physician, 21-30 minutes | 13 | $1,989 | $105 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 27 | $1,855 | $66 |
| Administration of influenza virus vaccine | 36 | $784 | $21 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 28 | $418 | $13 |
| Administration of pneumococcal vaccine | 19 | $402 | $21 |
| Urinalysis, manual test | 18 | $84 | $3 |
2020: 10 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 57 | $8,019 | $141 |
| Short return visit (20+ min) | 83 | $7,345 | $57 |
| Return visit (30+ min) | 67 | $6,889 | $83 |
| Telephone medical discussion with physician, 11-20 minutes | 44 | $3,378 | $50 |
| Pneumococcal vaccine, 23-valent | 18 | $2,103 | $117 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 32 | $1,952 | $61 |
| Administration of influenza virus vaccine | 38 | $801 | $21 |
| Administration of pneumococcal vaccine | 16 | $327 | $20 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 13 | $152 | $12 |
| Urinalysis, manual test | 18 | $69 | $3 |
2019: 11 services
| Short return visit (20+ min) | 164 | $13,650 | $59 |
| Return visit (30+ min) | 94 | $11,007 | $87 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 58 | $8,099 | $140 |
| Influenza vaccine, inactivated | 55 | $3,194 | $58 |
| Pneumococcal vaccine, 23-valent | 14 | $1,554 | $111 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,205 | $63 |
| Administration of influenza virus vaccine | 57 | $1,150 | $20 |
| Administration of pneumococcal vaccine | 19 | $383 | $20 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 11 | $243 | $16 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 15 | $215 | $14 |
| Urinalysis, manual test | 32 | $133 | $3 |
2018: 12 services
| Return visit (30+ min) | 74 | $9,439 | $85 |
| Short return visit (20+ min) | 127 | $9,266 | $54 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 53 | $7,330 | $138 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 44 | $4,298 | $57 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 12 | $2,333 | $194 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $1,940 | $84 |
| Influenza vaccine, inactivated | 34 | $1,822 | $54 |
| Administration of influenza virus vaccine | 38 | $961 | $25 |
| Hospital discharge day management, 30 minutes or less | 13 | $774 | $60 |
| Administration of pneumococcal vaccine | 20 | $506 | $25 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 16 | $260 | $15 |
| Urinalysis, manual test | 20 | $82 | $3 |
2017: 10 services
| Return visit (30+ min) | 76 | $10,503 | $80 |
| Short return visit (20+ min) | 112 | $9,184 | $54 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 52 | $6,983 | $134 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $2,439 | $79 |
| Influenza vaccine split virus, preservative free | 40 | $1,958 | $48 |
| Administration of influenza virus vaccine | 44 | $1,400 | $31 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,196 | $54 |
| Pneumococcal vaccine, 23-valent | 12 | $1,136 | $95 |
| Administration of pneumococcal vaccine | 19 | $591 | $31 |
| Urinalysis, manual test | 23 | $141 | $3 |
2016: 8 services
| Return visit (30+ min) | 77 | $8,993 | $81 |
| Pneumococcal vaccine, 13-valent | 41 | $7,151 | $174 |
| Short return visit (20+ min) | 92 | $6,903 | $54 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 46 | $5,954 | $129 |
| Administration of pneumococcal vaccine | 49 | $1,466 | $30 |
| Influenza vaccine split virus, preservative free | 29 | $1,120 | $39 |
| Administration of influenza virus vaccine | 32 | $987 | $30 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 11 | $187 | $14 |
2015: 8 services
| Return visit (30+ min) | 94 | $12,286 | $81 |
| Pneumococcal vaccine, 13-valent | 37 | $6,092 | $165 |
| Short return visit (20+ min) | 95 | $5,955 | $53 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 38 | $4,827 | $127 |
| Influenza vaccine split virus, preservative free | 29 | $1,026 | $35 |
| Administration of pneumococcal vaccine | 31 | $854 | $28 |
| Administration of influenza virus vaccine | 28 | $841 | $30 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 11 | $172 | $14 |
2014: 6 services
| Return visit (30+ min) | 79 | $9,132 | $78 |
| Short return visit (20+ min) | 71 | $4,899 | $51 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 21 | $2,667 | $127 |
| New patient visit (45+ min) | 11 | $1,371 | $125 |
| Influenza vaccine split virus, preservative free | 15 | $489 | $33 |
| Administration of influenza virus vaccine | 16 | $476 | $30 |
2013: 2 services
| Return visit (30+ min) | 60 | $7,588 | $80 |
| Short return visit (20+ min) | 77 | $5,758 | $55 |
Drugs they prescribed that Part D paid
$116,623
Pharmacies billed $116,623 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
2,011 generic and 188 brand-name prescriptions · $116,623 in drug cost · 73 antibiotic prescriptions to 54 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 27 | $43,749 | $1,620 |
| Eliquis | 20 | $10,767 | $538 |
| Rosuvastatin | 236 | $2,586 | $11 |
| Atorvastatin | 207 | $1,976 | $10 |
| Synthroid | 14 | $1,400 | $100 |
See all 47 drugs
| Jardiance | 27 | $43,749 | $1,620 |
| Eliquis | 20 | $10,767 | $538 |
| Rosuvastatin | 236 | $2,586 | $11 |
| Atorvastatin | 207 | $1,976 | $10 |
| Synthroid | 14 | $1,400 | $100 |
| Levothyroxine | 134 | $1,392 | $10 |
| Celecoxib | 15 | $1,079 | $72 |
| Losartan | 98 | $1,016 | $10 |
| Metoprolol | 51 | $706 | $14 |
| Albuterol Sulfate Hfa | 26 | $692 | $27 |
| Metformin | 72 | $668 | $9 |
| Diltiazem 24hr Er (Cd) | 12 | $656 | $55 |
| Lisinopril | 65 | $635 | $10 |
| Atenolol | 41 | $600 | $15 |
| Amlodipine Besylate | 102 | $572 | $6 |
| Gabapentin | 33 | $562 | $17 |
| Pantoprazole | 27 | $429 | $16 |
| Allopurinol | 22 | $402 | $18 |
| Estradiol | 21 | $395 | $19 |
| Escitalopram | 14 | $354 | $25 |
| Alendronate | 36 | $342 | $9 |
| Duloxetine | 20 | $339 | $17 |
| Pregabalin | 14 | $328 | $23 |
| Glipizide | 23 | $298 | $13 |
| Lovastatin | 15 | $288 | $19 |
| Simvastatin | 42 | $280 | $7 |
| Triamterene-Hydrochlorothiazid | 25 | $272 | $11 |
| Sertraline | 31 | $249 | $8 |
| Tamsulosin | 15 | $245 | $16 |
| Glipizide Er | 20 | $236 | $12 |
| Pravastatin | 18 | $220 | $12 |
| Rizatriptan | 14 | $197 | $14 |
| Hydrochlorothiazide | 60 | $186 | $3 |
| Losartan-Hydrochlorothiazide | 11 | $179 | $16 |
| Omeprazole | 22 | $156 | $7 |
| Metoprolol | 26 | $154 | $6 |
| Nitrofurantoin Mono-Macro | 13 | $124 | $10 |
| Amoxicillin-Clavulanate Potass | 14 | $123 | $9 |
| Carvedilol | 15 | $116 | $8 |
| Metformin Hcl Er | 16 | $114 | $7 |
| Fluoxetine | 16 | $113 | $7 |
| Zolpidem | 24 | $107 | $4 |
| Paroxetine | 12 | $90 | $7 |
| Clonazepam | 19 | $74 | $4 |
| Lorazepam | 14 | $70 | $5 |
| Meloxicam | 11 | $27 | $2 |
| Paxlovid | 14 | $0 | $0 |
Year by year
| 2024 | 2,214 | 315 | None | 8% | $116,623 |
| 2023 | 2,016 | 313 | 1% (17) | 9% | $116,410 |
| 2022 | 2,031 | 268 | 1% (18) | 9% | $113,807 |
| 2021 | 1,738 | 244 | 1% (20) | None | $93,977 |
| 2020 | 1,515 | 230 | 3% (41) | None | $120,622 |
| 2019 | 1,479 | 290 | 3% (44) | None | $78,706 |
| 2018 | 1,753 | 291 | 4% (64) | None | $88,352 |
| 2017 | 2,101 | 264 | 3% (60) | 15% | $89,554 |
| 2016 | 2,281 | 245 | 1% (25) | 18% | $99,032 |
| 2015 | 2,323 | 231 | 1% (20) | 19% | $82,974 |
| 2014 | 1,651 | 193 | 2% (27) | None | $70,258 |
| 2013 | 1,386 | 154 | 2% (24) | 23% | $61,589 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 42 drugs
| Jardiance | 15 | $20,791 | $1,386 |
| Eliquis | 25 | $19,851 | $794 |
| Rosuvastatin | 136 | $2,276 | $17 |
| Levothyroxine | 161 | $2,046 | $13 |
| Atorvastatin | 165 | $1,850 | $11 |
| Gabapentin | 51 | $1,735 | $34 |
| Metoprolol | 48 | $1,062 | $22 |
| Losartan | 72 | $985 | $14 |
| Metformin | 67 | $908 | $14 |
| Amlodipine Besylate | 121 | $907 | $7 |
| Fluoxetine | 12 | $750 | $63 |
| Pantoprazole | 37 | $728 | $20 |
| Tamsulosin | 17 | $559 | $33 |
| Atenolol | 51 | $554 | $11 |
| Lisinopril | 65 | $511 | $8 |
| Albuterol Sulfate Hfa | 15 | $510 | $34 |
| Rizatriptan | 14 | $483 | $35 |
| Alendronate | 33 | $445 | $13 |
| Allopurinol | 21 | $424 | $20 |
| Omeprazole | 28 | $416 | $15 |
| Sertraline | 37 | $404 | $11 |
| Estradiol | 13 | $383 | $29 |
| Progesterone | 12 | $305 | $25 |
| Digoxin | 12 | $291 | $24 |
| Escitalopram | 13 | $246 | $19 |
| Paxlovid (Eua) | 23 | $242 | $11 |
| Triamterene-Hydrochlorothiazid | 17 | $228 | $13 |
| Trazodone | 21 | $203 | $10 |
| Simvastatin | 35 | $185 | $5 |
| Glipizide | 26 | $180 | $7 |
| Pravastatin | 18 | $180 | $10 |
| Zolpidem | 22 | $161 | $7 |
| Pregabalin | 11 | $154 | $14 |
| Hydrochlorothiazide | 39 | $147 | $4 |
| Nitrofurantoin Mono-Macro | 11 | $133 | $12 |
| Metoprolol | 17 | $131 | $8 |
| Lorazepam | 14 | $99 | $7 |
| Azithromycin | 11 | $71 | $6 |
| Clonazepam | 12 | $62 | $5 |
| Furosemide | 11 | $48 | $4 |
| Temazepam | 11 | $36 | $3 |
| Meloxicam | 14 | $32 | $2 |
2022: 41 drugs
| Eliquis | 13 | $11,562 | $889 |
| Janumet | 11 | $6,136 | $558 |
| Rosuvastatin | 146 | $3,206 | $22 |
| Levothyroxine | 153 | $2,445 | $16 |
| Gabapentin | 56 | $2,376 | $42 |
| Fluoxetine | 27 | $1,471 | $54 |
| Atorvastatin | 166 | $1,376 | $8 |
| Metoprolol | 53 | $1,045 | $20 |
| Pantoprazole | 46 | $725 | $16 |
| Amlodipine Besylate | 114 | $717 | $6 |
| Omeprazole | 29 | $679 | $23 |
| Rizatriptan | 18 | $646 | $36 |
| Losartan | 59 | $478 | $8 |
| Lisinopril | 84 | $444 | $5 |
| Duloxetine | 14 | $432 | $31 |
| Tamsulosin | 20 | $412 | $21 |
| Trazodone | 16 | $396 | $25 |
| Simvastatin | 56 | $381 | $7 |
| Metformin | 54 | $380 | $7 |
| Estradiol | 12 | $378 | $32 |
| Bupropion Xl | 13 | $377 | $29 |
| Alendronate | 25 | $367 | $15 |
| Atenolol | 37 | $336 | $9 |
| Allopurinol | 21 | $314 | $15 |
| Pioglitazone | 12 | $301 | $25 |
| Escitalopram | 20 | $273 | $14 |
| Triamterene-Hydrochlorothiazid | 17 | $223 | $13 |
| Fluticasone Propionate | 13 | $199 | $15 |
| Sertraline | 33 | $191 | $6 |
| Pravastatin | 14 | $177 | $13 |
| Hydrochlorothiazide | 47 | $137 | $3 |
| Temazepam | 18 | $116 | $6 |
| Paxlovid (Eua) | 11 | $115 | $10 |
| Benazepril | 11 | $97 | $9 |
| Glipizide | 28 | $67 | $2 |
| Glimepiride | 13 | $66 | $5 |
| Zolpidem | 15 | $63 | $4 |
| Furosemide | 12 | $57 | $5 |
| Metoprolol | 11 | $54 | $5 |
| Lorazepam | 11 | $46 | $4 |
| Lisinopril-Hydrochlorothiazide | 11 | $45 | $4 |
2021: 41 drugs
| Eliquis | 18 | $11,450 | $636 |
| Xarelto | 13 | $9,316 | $717 |
| Levothyroxine | 138 | $3,192 | $23 |
| Gabapentin | 38 | $2,058 | $54 |
| Atorvastatin | 132 | $1,678 | $13 |
| Rosuvastatin | 58 | $1,545 | $27 |
| Pantoprazole | 33 | $1,055 | $32 |
| Metoprolol | 33 | $983 | $30 |
| Duloxetine | 19 | $925 | $49 |
| Amlodipine Besylate | 96 | $854 | $9 |
| Losartan | 50 | $757 | $15 |
| Omeprazole | 27 | $579 | $21 |
| Simvastatin | 60 | $503 | $8 |
| Propranolol | 12 | $465 | $39 |
| Tamsulosin | 19 | $443 | $23 |
| Atenolol | 43 | $414 | $10 |
| Lisinopril | 61 | $391 | $6 |
| Metformin | 41 | $391 | $10 |
| Triamterene-Hydrochlorothiazid | 21 | $388 | $18 |
| Alendronate | 26 | $356 | $14 |
| Hydrochlorothiazide | 57 | $329 | $6 |
| Escitalopram | 16 | $312 | $20 |
| Trazodone | 17 | $303 | $18 |
| Fluoxetine | 19 | $264 | $14 |
| Fluticasone Propionate | 11 | $248 | $23 |
| Zolpidem | 34 | $248 | $7 |
| Pravastatin | 14 | $191 | $14 |
| Temazepam | 17 | $172 | $10 |
| Benazepril | 12 | $148 | $12 |
| Lisinopril-Hydrochlorothiazide | 18 | $131 | $7 |
| Metoprolol | 13 | $124 | $10 |
| Furosemide | 14 | $116 | $8 |
| Sertraline | 20 | $106 | $5 |
| Glipizide | 19 | $102 | $5 |
| Lovastatin | 13 | $93 | $7 |
| Tramadol | 13 | $89 | $7 |
| Alprazolam | 14 | $69 | $5 |
| Glimepiride | 12 | $63 | $5 |
| Ciprofloxacin | 13 | $54 | $4 |
| Clonazepam | 16 | $52 | $3 |
| Meloxicam | 11 | $17 | $2 |
2020: 35 drugs
| Eliquis | 23 | $16,789 | $730 |
| Levothyroxine | 91 | $2,363 | $26 |
| Gabapentin | 39 | $1,594 | $41 |
| Atorvastatin | 97 | $1,207 | $12 |
| Rosuvastatin | 34 | $1,204 | $35 |
| Metoprolol | 39 | $1,181 | $30 |
| Amlodipine Besylate | 89 | $795 | $9 |
| Losartan | 48 | $641 | $13 |
| Omeprazole | 34 | $561 | $16 |
| Pantoprazole | 27 | $553 | $20 |
| Metformin | 43 | $518 | $12 |
| Tamsulosin | 19 | $466 | $25 |
| Hydrochlorothiazide | 48 | $435 | $9 |
| Simvastatin | 49 | $410 | $8 |
| Trazodone | 18 | $402 | $22 |
| Alendronate | 30 | $353 | $12 |
| Lisinopril | 50 | $296 | $6 |
| Atenolol | 28 | $282 | $10 |
| Pravastatin | 14 | $267 | $19 |
| Lovastatin | 17 | $243 | $14 |
| Triamterene-Hydrochlorothiazid | 11 | $232 | $21 |
| Fluoxetine | 14 | $224 | $16 |
| Escitalopram | 13 | $205 | $16 |
| Hydrocodone-Acetaminophen | 20 | $183 | $9 |
| Allopurinol | 14 | $168 | $12 |
| Furosemide | 20 | $168 | $8 |
| Olmesartan Medoxomil | 15 | $152 | $10 |
| Temazepam | 12 | $140 | $12 |
| Zolpidem | 33 | $126 | $4 |
| Metoprolol | 14 | $126 | $9 |
| Glipizide | 17 | $112 | $7 |
| Sertraline | 12 | $100 | $8 |
| Lisinopril-Hydrochlorothiazide | 18 | $70 | $4 |
| Tramadol | 15 | $64 | $4 |
| Alprazolam | 12 | $15 | $1 |
2019: 35 drugs
| Eliquis | 22 | $15,210 | $691 |
| Levothyroxine | 79 | $1,619 | $20 |
| Atorvastatin | 97 | $1,321 | $14 |
| Amlodipine Besylate | 89 | $903 | $10 |
| Metoprolol | 27 | $815 | $30 |
| Rosuvastatin | 17 | $777 | $46 |
| Simvastatin | 59 | $486 | $8 |
| Losartan | 37 | $465 | $13 |
| Gabapentin | 18 | $454 | $25 |
| Omeprazole | 29 | $431 | $15 |
| Metformin | 46 | $417 | $9 |
| Lisinopril | 48 | $368 | $8 |
| Hydrochlorothiazide | 32 | $356 | $11 |
| Lovastatin | 25 | $329 | $13 |
| Trazodone | 11 | $317 | $29 |
| Escitalopram | 21 | $271 | $13 |
| Glipizide | 19 | $225 | $12 |
| Pantoprazole | 28 | $220 | $8 |
| Tramadol | 22 | $209 | $10 |
| Nitrofurantoin Mono-Macro | 15 | $199 | $13 |
| Triamterene-Hydrochlorothiazid | 16 | $197 | $12 |
| Alendronate | 27 | $186 | $7 |
| Furosemide | 22 | $180 | $8 |
| Sertraline | 27 | $178 | $7 |
| Hydrocodone-Acetaminophen | 19 | $178 | $9 |
| Atenolol | 24 | $172 | $7 |
| Zolpidem | 33 | $156 | $5 |
| Losartan-Hydrochlorothiazide | 15 | $144 | $10 |
| Metoprolol | 13 | $138 | $11 |
| Triamcinolone Acetonide | 13 | $108 | $8 |
| Ciprofloxacin | 19 | $82 | $4 |
| Metformin Hcl Er | 11 | $49 | $4 |
| Clonazepam | 12 | $48 | $4 |
| Alprazolam | 11 | $35 | $3 |
| Lorazepam | 11 | $29 | $3 |
2018: 39 drugs
| Eliquis | 14 | $9,084 | $649 |
| Levothyroxine | 126 | $3,081 | $24 |
| Atorvastatin | 124 | $2,205 | $18 |
| Rosuvastatin | 22 | $1,832 | $83 |
| Ventolin Hfa | 12 | $769 | $64 |
| Amlodipine Besylate | 76 | $576 | $8 |
| Lovastatin | 34 | $573 | $17 |
| Metoprolol | 24 | $533 | $22 |
| Fenofibrate | 12 | $529 | $44 |
| Hydrochlorothiazide | 50 | $524 | $10 |
| Simvastatin | 54 | $514 | $10 |
| Losartan | 40 | $440 | $11 |
| Lisinopril | 53 | $410 | $8 |
| Gabapentin | 30 | $396 | $13 |
| Metformin | 43 | $382 | $9 |
| Pantoprazole | 32 | $366 | $11 |
| Trazodone | 12 | $356 | $30 |
| Omeprazole | 34 | $333 | $10 |
| Hydrocodone-Acetaminophen | 28 | $308 | $11 |
| Escitalopram | 18 | $294 | $16 |
| Tramadol | 33 | $265 | $8 |
| Valsartan | 12 | $257 | $21 |
| Alendronate | 27 | $233 | $9 |
| Glipizide | 17 | $188 | $11 |
| Zolpidem | 30 | $175 | $6 |
| Carvedilol | 22 | $170 | $8 |
| Triamterene-Hydrochlorothiazid | 19 | $162 | $9 |
| Atenolol | 32 | $162 | $5 |
| Furosemide | 35 | $161 | $5 |
| Sertraline | 31 | $160 | $5 |
| Lisinopril-Hydrochlorothiazide | 24 | $143 | $6 |
| Metoprolol | 19 | $112 | $6 |
| Tamsulosin | 11 | $109 | $10 |
| Diltiazem 24hr Er (Cd) | 12 | $107 | $9 |
| Losartan-Hydrochlorothiazide | 11 | $98 | $9 |
| Ciprofloxacin | 13 | $94 | $7 |
| Venlafaxine Hcl Er | 14 | $94 | $7 |
| Fluoxetine | 16 | $92 | $6 |
| Lactulose | 17 | $24 | $1 |
2017: 45 drugs
| Pradaxa | 12 | $4,540 | $378 |
| Levothyroxine | 132 | $3,009 | $23 |
| Atorvastatin | 132 | $2,258 | $17 |
| Rosuvastatin | 12 | $1,175 | $98 |
| Ventolin Hfa | 14 | $948 | $68 |
| Pantoprazole | 55 | $833 | $15 |
| Metformin | 79 | $672 | $9 |
| Metoprolol | 12 | $562 | $47 |
| Lovastatin | 32 | $560 | $18 |
| Hydrochlorothiazide | 70 | $488 | $7 |
| Amlodipine Besylate | 80 | $468 | $6 |
| Pravastatin | 19 | $461 | $24 |
| Losartan | 55 | $456 | $8 |
| Lisinopril | 75 | $446 | $6 |
| Alendronate | 50 | $436 | $9 |
| Allopurinol | 16 | $397 | $25 |
| Hydrocodone-Acetaminophen | 24 | $381 | $16 |
| Omeprazole | 37 | $370 | $10 |
| Simvastatin | 62 | $336 | $5 |
| Gabapentin | 28 | $321 | $11 |
| Valsartan | 13 | $317 | $24 |
| Diltiazem 24hr Er | 12 | $307 | $26 |
| Zolpidem | 28 | $281 | $10 |
| Lactulose | 15 | $254 | $17 |
| Lisinopril-Hydrochlorothiazide | 34 | $223 | $7 |
| Amoxicillin-Clavulanate Potass | 18 | $214 | $12 |
| Triamterene-Hydrochlorothiazid | 22 | $203 | $9 |
| Glyburide | 13 | $188 | $14 |
| Clopidogrel | 11 | $184 | $17 |
| Sertraline | 31 | $177 | $6 |
| Furosemide | 48 | $157 | $3 |
| Atenolol | 41 | $156 | $4 |
| Metformin Hcl Er | 15 | $152 | $10 |
| Escitalopram | 18 | $145 | $8 |
| Tramadol | 32 | $131 | $4 |
| Glipizide | 25 | $126 | $5 |
| Venlafaxine Hcl Er | 14 | $124 | $9 |
| Hydralazine | 11 | $113 | $10 |
| Terazosin | 13 | $108 | $8 |
| Azithromycin | 17 | $102 | $6 |
| Benazepril | 13 | $100 | $8 |
| Citalopram Hbr | 22 | $96 | $4 |
| Metoprolol | 20 | $92 | $5 |
| Ciprofloxacin | 18 | $80 | $4 |
| Carvedilol | 13 | $67 | $5 |
2016: 58 drugs
| Xarelto | 17 | $8,202 | $482 |
| Januvia | 20 | $7,415 | $371 |
| Novolog Flexpen | 13 | $6,861 | $528 |
| Advair Diskus | 15 | $6,594 | $440 |
| Pradaxa | 12 | $4,217 | $351 |
| Levothyroxine | 129 | $2,713 | $21 |
| Atorvastatin | 133 | $1,808 | $14 |
| Benicar | 12 | $1,423 | $119 |
| Valsartan | 19 | $788 | $41 |
| Duloxetine | 11 | $759 | $69 |
| Metformin | 99 | $688 | $7 |
| Lovastatin | 43 | $662 | $15 |
| Amlodipine Besylate | 122 | $659 | $5 |
| Losartan | 99 | $648 | $7 |
| Pravastatin | 26 | $620 | $24 |
| Hydrocodone-Acetaminophen | 18 | $572 | $32 |
| Doxazosin Mesylate | 18 | $530 | $29 |
| Valsartan-Hydrochlorothiazide | 14 | $525 | $38 |
| Lisinopril | 85 | $509 | $6 |
| Metformin Hcl Er | 22 | $450 | $20 |
| Bd Ultra-Fine Pen Needle | 12 | $448 | $37 |
| Hydrochlorothiazide | 76 | $445 | $6 |
| Potassium Chloride | 19 | $439 | $23 |
| Gabapentin | 23 | $436 | $19 |
| Metoprolol | 16 | $433 | $27 |
| Simvastatin | 105 | $396 | $4 |
| Digoxin | 17 | $387 | $23 |
| Allopurinol | 15 | $349 | $23 |
| Pantoprazole | 43 | $325 | $8 |
| Atenolol | 96 | $318 | $3 |
| Levoxyl | 12 | $313 | $26 |
| Omeprazole | 32 | $307 | $10 |
| Triamterene-Hydrochlorothiazid | 26 | $302 | $12 |
| Zolpidem | 18 | $270 | $15 |
| Lisinopril-Hydrochlorothiazide | 34 | $252 | $7 |
| Famotidine | 12 | $241 | $20 |
| Doxycycline Monohydrate | 11 | $234 | $21 |
| Amoxicillin-Clavulanate Potass | 17 | $229 | $13 |
| Escitalopram | 11 | $217 | $20 |
| Klor-Con 8 | 11 | $209 | $19 |
| Alendronate | 29 | $199 | $7 |
| Synthroid | 11 | $199 | $18 |
| Furosemide | 53 | $197 | $4 |
| Lactulose | 19 | $190 | $10 |
| Glyburide | 13 | $174 | $13 |
| Citalopram Hbr | 34 | $130 | $4 |
| Ciprofloxacin | 17 | $116 | $7 |
| Trazodone | 17 | $115 | $7 |
| Sertraline | 25 | $113 | $5 |
| Estradiol | 13 | $106 | $8 |
| Glipizide | 15 | $105 | $7 |
| Hydralazine | 17 | $103 | $6 |
| Benazepril | 16 | $96 | $6 |
| Fenofibrate | 13 | $91 | $7 |
| Ranitidine | 12 | $74 | $6 |
| Meloxicam | 12 | $70 | $6 |
| Terazosin | 11 | $59 | $5 |
| Metoprolol | 14 | $51 | $4 |
2015: 60 drugs
| Spiriva | 17 | $5,275 | $310 |
| Novolog Flexpen | 11 | $4,706 | $428 |
| Advair Diskus | 11 | $4,486 | $408 |
| Januvia | 12 | $4,283 | $357 |
| Levothyroxine | 113 | $2,630 | $23 |
| Premarin | 15 | $2,045 | $136 |
| Celecoxib | 11 | $1,888 | $172 |
| Atorvastatin | 107 | $1,621 | $15 |
| Valsartan | 17 | $1,409 | $83 |
| Valsartan-Hydrochlorothiazide | 20 | $1,014 | $51 |
| Amlodipine Besylate | 152 | $770 | $5 |
| Losartan | 106 | $670 | $6 |
| Proair Hfa | 13 | $669 | $51 |
| Fenofibrate | 13 | $589 | $45 |
| Hydrochlorothiazide | 75 | $555 | $7 |
| Pravastatin | 17 | $541 | $32 |
| Potassium Chloride | 26 | $514 | $20 |
| Mirtazapine | 12 | $501 | $42 |
| Lovastatin | 56 | $487 | $9 |
| Triamterene-Hydrochlorothiazid | 35 | $481 | $14 |
| Metformin | 74 | $472 | $6 |
| Simvastatin | 111 | $464 | $4 |
| Digoxin | 17 | $436 | $26 |
| Doxazosin Mesylate | 18 | $429 | $24 |
| Atenolol | 121 | $408 | $3 |
| Lactulose | 16 | $403 | $25 |
| Gabapentin | 23 | $399 | $17 |
| Metoprolol | 11 | $381 | $35 |
| Synthroid | 13 | $367 | $28 |
| Lisinopril | 76 | $359 | $5 |
| Omeprazole | 23 | $357 | $16 |
| Hydrocodone-Acetaminophen | 11 | $338 | $31 |
| Allopurinol | 15 | $337 | $22 |
| Montelukast | 18 | $249 | $14 |
| Diltiazem Er | 11 | $247 | $22 |
| Lisinopril-Hydrochlorothiazide | 49 | $239 | $5 |
| Pantoprazole | 25 | $226 | $9 |
| Metformin Hcl Er | 21 | $217 | $10 |
| Fluticasone Propionate | 20 | $214 | $11 |
| Furosemide | 50 | $213 | $4 |
| Zolpidem | 23 | $207 | $9 |
| Glipizide Er | 13 | $174 | $13 |
| Lorazepam | 21 | $173 | $8 |
| Escitalopram | 13 | $163 | $13 |
| Ciprofloxacin | 24 | $156 | $6 |
| Isosorbide Mononitrate Er | 11 | $151 | $14 |
| Metoprolol | 25 | $130 | $5 |
| Hydralazine | 20 | $124 | $6 |
| Warfarin | 11 | $108 | $10 |
| Azithromycin | 17 | $104 | $6 |
| Sertraline | 26 | $102 | $4 |
| Donepezil | 20 | $99 | $5 |
| Trazodone | 16 | $91 | $6 |
| Estradiol | 16 | $89 | $6 |
| Citalopram Hbr | 23 | $86 | $4 |
| Benazepril | 13 | $81 | $6 |
| Ranitidine | 11 | $79 | $7 |
| Pramipexole Dihydrochloride | 12 | $76 | $6 |
| Terazosin | 17 | $73 | $4 |
| Alprazolam | 11 | $41 | $4 |
2014: 39 drugs
| Celebrex | 16 | $4,799 | $300 |
| Metformin Hcl Er | 13 | $4,482 | $345 |
| Advair Diskus | 11 | $4,203 | $382 |
| Dexilant | 12 | $2,174 | $181 |
| Levothyroxine | 96 | $1,834 | $19 |
| Atorvastatin | 71 | $1,659 | $23 |
| Valsartan-Hydrochlorothiazide | 20 | $1,119 | $56 |
| Amlodipine Besylate | 119 | $884 | $7 |
| Fenofibrate | 17 | $873 | $51 |
| Metronidazole | 11 | $768 | $70 |
| Hydrocodone-Acetaminophen | 20 | $735 | $37 |
| Lisinopril | 97 | $706 | $7 |
| Fluticasone Propionate | 33 | $513 | $16 |
| Simvastatin | 59 | $492 | $8 |
| Losartan | 36 | $456 | $13 |
| Lovastatin | 37 | $435 | $12 |
| Atenolol | 69 | $367 | $5 |
| Metformin | 38 | $365 | $10 |
| Potassium Chloride | 15 | $361 | $24 |
| Triamterene-Hydrochlorothiazid | 28 | $339 | $12 |
| Pravastatin | 16 | $290 | $18 |
| Omeprazole | 22 | $264 | $12 |
| Hydrochlorothiazide | 62 | $254 | $4 |
| Hydralazine | 19 | $240 | $13 |
| Amox Tr-Potassium Clavulanate | 14 | $237 | $17 |
| Warfarin | 30 | $214 | $7 |
| Lisinopril-Hydrochlorothiazide | 33 | $199 | $6 |
| Gabapentin | 15 | $183 | $12 |
| Zolpidem | 21 | $178 | $8 |
| Metoprolol | 24 | $147 | $6 |
| Alprazolam | 24 | $146 | $6 |
| Sertraline | 19 | $140 | $7 |
| Pantoprazole | 11 | $129 | $12 |
| Furosemide | 29 | $108 | $4 |
| Estradiol | 13 | $104 | $8 |
| Ciprofloxacin | 17 | $92 | $5 |
| Lorazepam | 12 | $81 | $7 |
| Carvedilol | 12 | $81 | $7 |
| Benazepril | 11 | $68 | $6 |
2013: 43 drugs
| Lantus Solostar | 19 | $4,938 | $260 |
| Celebrex | 18 | $4,556 | $253 |
| Diovan | 28 | $4,335 | $155 |
| Valsartan-Hydrochlorothiazide | 22 | $1,890 | $86 |
| Zolpidem Tartrate Er | 13 | $1,560 | $120 |
| Prempro | 11 | $1,079 | $98 |
| Levothyroxine | 71 | $941 | $13 |
| Metoprolol | 20 | $914 | $46 |
| Atorvastatin | 35 | $911 | $26 |
| Amlodipine Besylate | 108 | $887 | $8 |
| Fluticasone Propionate | 22 | $580 | $26 |
| Losartan | 32 | $570 | $18 |
| Lisinopril | 75 | $514 | $7 |
| Simvastatin | 47 | $494 | $11 |
| Lovastatin | 36 | $458 | $13 |
| Potassium Chloride | 13 | $424 | $33 |
| Fluoxetine | 12 | $395 | $33 |
| Atenolol | 53 | $373 | $7 |
| Pravastatin | 21 | $302 | $14 |
| Quinapril | 20 | $251 | $13 |
| Pantoprazole | 18 | $247 | $14 |
| Doxazosin Mesylate | 16 | $230 | $14 |
| Triamterene-Hctz | 20 | $218 | $11 |
| Sertraline | 29 | $211 | $7 |
| Nifedipine Er | 11 | $204 | $19 |
| Glyburide | 14 | $190 | $14 |
| Lisinopril-Hydrochlorothiazide | 25 | $181 | $7 |
| Carvedilol | 14 | $179 | $13 |
| Metformin | 23 | $173 | $8 |
| Hydrochlorothiazide | 38 | $172 | $5 |
| Hydrocodone-Acetaminophen | 16 | $166 | $10 |
| Warfarin | 23 | $161 | $7 |
| Furosemide | 30 | $150 | $5 |
| Ciprofloxacin | 19 | $146 | $8 |
| Bisoprolol | 12 | $142 | $12 |
| Gabapentin | 13 | $135 | $10 |
| Ranitidine | 16 | $121 | $8 |
| Clonazepam | 11 | $99 | $9 |
| Benazepril | 11 | $88 | $8 |
| Lorazepam | 15 | $84 | $6 |
| Alprazolam | 14 | $80 | $6 |
| Zolpidem | 14 | $79 | $6 |
| Metoprolol | 18 | $75 | $4 |
Money from drug and device companies
$32 in 2025
| 2025 | 1 | 1 | None | $32 |
| 2024 | 4 | 4 | None | $185 |
| 2023 | 4 | 4 | None | $89 |
| 2020 | 1 | 1 | None | $15 |
| 2019 | 3 | 4 | None | $303 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Merck Sharp & Dohme | M-M-R II | $32 | 1 payment
|
See the published payment
| Merck Sharp & Dohme | Meals · 2025-02-11 | M-M-R II | $32 |
See earlier years (2024, 2023, 2020, 2019)
2024: $185
| GlaxoSmithKline | Arexvy | $120 | 1 payment
|
| Otsuka America Pharmaceutical | Rexulti | $27 | 1 payment
|
| Tactile Systems Technology | Flexitouch Plus | $22 | 1 payment
|
| Novo Nordisk | None | $17 | 1 payment
|
2023: $89
| Takeda Pharmaceuticals U.S.A. | Trintellix | $30 | 1 payment
|
| GlaxoSmithKline | Shingrix | $22 | 1 payment
|
| Otsuka America Pharmaceutical | Rexulti | $22 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $15 | 1 payment
|
2020: $15
| Pfizer | Cologuard | $15 | 1 payment
|
2019: $303
| Amgen | Aimovig | $150 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Tagrisso | $111 | 1 payment
|
| Biotronik | None | $42 | 1 payment
|
Professional record
- NPI
- 1255332953
- Licence
- CA A90362California A90362: Current · expires 2027-03-31
- Group
- John Muir Physician Network · Sutter Bay Medical Foundation
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X); Federal specialty code 174400000X (174400000X)
- Mailing address
- 1450 Treat Blvd, Suite 300, Walnut Creek, CA, 94597
- NPI first listed
- 2005-08-03
- NPI last updated
- 2016-11-21
This is when the NPI record was last certified, not a medical board exam.